BioNTech SE (LON:0A3M)

BioNTech SE Ratios and Metrics

Market cap in millions GBP. Fiscal year is January - December.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 12, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Capitalization	16,531	17,008	21,821	19,696	30,298	45,983
Market Cap Growth	-23.22%	-22.06%	10.79%	-34.99%	-34.11%	219.84%
Enterprise Value	4,581	4,558	7,152	6,778	19,593	44,179
Last Close Price	69.03	70.63	89.29	83.40	122.84	187.25
PE Ratio	-	-	-	24.40	3.62	5.32
PS Ratio	6.60	6.79	9.59	5.94	1.97	2.89
PB Ratio	0.99	1.01	1.36	1.12	1.70	4.60
P/TBV Ratio	1.10	1.13	1.45	1.19	1.72	4.68
P/FCF Ratio	67.46	69.41	-	4.43	2.58	71.83
P/OCF Ratio	41.56	42.76	127.04	4.23	2.52	61.54
EV/Sales Ratio	1.80	1.82	3.14	2.05	1.28	2.77
EV/EBITDA Ratio	-	-	-	7.04	1.84	3.53
EV/EBIT Ratio	-	-	-	8.04	1.85	3.54
EV/FCF Ratio	18.69	18.60	-	1.53	1.67	69.01
Debt / Equity Ratio	0.01	0.01	0.01	0.01	0.01	0.03
Debt / EBITDA Ratio	-	-	-	0.19	0.02	0.02
Debt / FCF Ratio	0.95	0.95	-	0.04	0.02	0.40
Net Debt / Equity Ratio	-0.70	-0.70	-0.80	-0.81	-0.69	-0.15
Net Debt / EBITDA Ratio	11.99	11.99	13.27	-14.71	-1.16	-0.12
Net Debt / FCF Ratio	-47.96	-47.96	197.84	-3.19	-1.05	-2.33
Asset Turnover	0.13	0.13	0.12	0.17	0.89	2.09
Inventory Turnover	3.10	3.10	1.69	1.51	6.36	10.28
Quick Ratio	6.87	6.87	6.88	9.12	7.19	4.15
Current Ratio	7.54	7.54	7.45	9.43	7.43	4.33
Return on Equity (ROE)	-5.88%	-5.88%	-3.36%	4.62%	59.06%	155.18%
Return on Assets (ROA)	-3.56%	-3.56%	-3.53%	2.62%	38.09%	102.25%
Return on Invested Capital (ROIC)	-25.47%	-26.47%	-33.23%	15.07%	106.34%	195.58%
Return on Capital Employed (ROCE)	-6.40%	-6.40%	-6.40%	4.60%	58.60%	120.20%
Earnings Yield	-6.00%	-5.83%	-2.52%	4.10%	27.62%	18.80%
FCF Yield	1.48%	1.44%	-0.30%	22.56%	38.78%	1.39%
Buyback Yield / Dilution	-0.54%	-0.54%	0.95%	2.84%	3.81%	-4.51%

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.